ClinicalTrials.Veeva

Menu
K

Krakowskie Centrum Medyczne | Krakow, Poland

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Filgotinib
Plozasiran
IPP-201101
Trilaciclib
Topotecan
AGA2118
VE202
Pyramax
Tralokinumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 11 total trials

A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women with Low Bone MasS (ARTEMIS)

The primary objective of this study is to determine the effect of treatment with AGA2118 versus placebo at Month 12 on lumbar spine bone mineral dens...

Enrolling
Postmenopausal Osteoporosis
Other: Placebo
Drug: AGA2118

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe hypertriglyceridemia (...

Enrolling
Severe Hypertriglyceridemia
Drug: Plozasiran Injection
Drug: Placebo

This is a multicenter, randomized, double-blind, placebo-controlled study to assess whether trilaciclib administered prior to topotecan is non-inferi...

Enrolling
Extensive-stage Small-cell Lung Cancer
Drug: Topotecan
Drug: Trilaciclib

A Phase 2 study to evaluate the safety, efficacy, and microbiota changes of VE202 in patients with mild to moderate ulcerative colitis (UC).

Enrolling
Colitis, Ulcerative
Ulcerative Colitis
Other: Vancomycin Placebo
Drug: Vancomycin Oral Capsule

Trial sponsors

G
Allergy Therapeutics logo
A
Arrowhead Pharmaceuticals logo
Celltrion Healthcare logo
G
I
LEO Pharma logo
S
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems